Welcome to our dedicated page for PLUN news (Ticker: PLUN), a resource for investors and traders seeking the latest updates and insights on PLUN stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PLUN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PLUN's position in the market.
Plutonian Acquisition Corp II (NYSE:PLUNU/PLUN) closed its initial public offering on April 29, 2026, selling 10,000,000 units at $10.00 per unit for aggregate gross proceeds of $100,000,000. Units began trading on NYSE April 28, 2026 under PLUNU; underlying shares and rights are expected to trade as PLUN and PLUNR when separated. A.G.P./Alliance Global Partners acted as sole book-running manager. The offering was made under an effective Form S-1 (File No. 333-293531) and copies of the prospectus are available as disclosed.